Inherited thrombophilia and risk factor interactions in a multigenerational Libyan family with deep vein thrombosis
Aml M. Masoud, Asma O. Jebril , Hussameddin H. Badi, Alamin M. Al-Trabelsi
Abstract
Deep vein thrombosis (DVT) is a major vascular disorder with significant morbidity and mortality. Inherited thrombophilia defects and acquired risk factors both contribute to its pathogenesis. Familial clustering suggests a strong genetic component, but data from Libyan families are limited. This study aimed to investigate inherited and acquired risk factors for DVT in a multigenerational Libyan family with a history of venous thrombosis. We recruited 10 family members: four symptomatic individuals, three asymptomatic individuals, and three controls. The index case had heterozygous factor V Leiden. We analyzed blood samples collected between October 2024 and January 2025 for fibrinogen, factor V, factor VIII, protein C, protein S, D-dimer, and complete blood count parameters. Body mass index and smoking status were also recorded. Factor V deficiency and elevated factor VIII were each observed in 6/10 participants. Elevated factor VIII was present in all four symptomatic patients. Fibrinogen was elevated in 2/10 participants, both asymptomatic. Protein C deficiency was found in 2/10 participants, and Protein S deficiency in; all were symptomatic. D-dimer was elevated in only one symptomatic patient. Obesity was present in 8/10 participants, and smoking in 3/10, all of whom were symptomatic males. However, between-group comparisons did not reach the significance level. These preliminary findings suggest that inherited thrombophilia factors, particularly factor V deficiency and elevated factor VIII, may contribute to DVT susceptibility in this family, with modifiable risk factors possibly acting as triggers.
Keywords
References
- Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. The Lancet. 2021; 398(10294): 64-77. doi: 10.1016/S0140-6736(20)32658-1
- AL-Belazi BJ, Abuhasina AE, Sherif FM. Thromboembolism in total hip and knee arthroplasty patients receiving low molecular weight heparin prophylaxis. Mediterranean Journal of Medicine and Medical Sciences. 2026; 2(2): 1-12. doi: 10.5281/zenodo.19398969
- Blanco A, Blanco G. Hemostasis. In: Blanco A, Blanco G, editors. Medical Biochemistry. 1st Ed., San Diego: Academic Press; 2017. ISBN: 9780128035504.
- Green D. Coagulation cascade. Hemodialysis International. 2006; 10(Suppl 2): S2-S4. doi: 10.1111/j.1542-4758.2006.00119.x
- Sarrar AM, Rafieda AM, Shaglouf DH, Elshwain WM. Venous and arterial thrombosis during oral contraceptive use in Libyan women. Mediterranean Journal of Medical Research. 2025; 2(4): 259-268. doi: 10.5281/zenodo. 17863440
- Rosing J, Tans G. Factor V. The International Journal of Biochemistry and Cell Biology. 1997; 29(10): 1123-1126. doi: 10.1016/S1357-2725(97)00040-X
- Padda IS, Zubair M, Citla Sridhar D. Protein C and S. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan. Updated 2025 Sep 14.
- Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. The Lancet. 2008; 371(9606): 75-84. doi: 10.1016/S0140-6736(08)60074-4
- Alshaikh NA. Protein S: A central regulator of blood coagulation. Clinical Laboratory. 2022; 68(8): 211010. doi: 10.7754/Clin.Lab.2021.211010
- Korotcenkov G. Factor V Leiden. Dimensions of Critical Care Nursing. 2022; 41(4): 190-199. doi: 10.1002/ ajh.24
- Pastori D, Menichelli D, Valeriani E, Pignatelli P. Factor V Leiden thrombophilia. In: Adam MP, Bick S, Mirzaa GM, et al., editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1999. PMID: 20301542.
- Lassila R. Management of coagulation factor VIII (FVIII) inhibitors. Thrombosis Research. 2019; 181(Suppl 1): S60-S61. doi: 10.1016/S0049-3848(19)30369-X
- Kamphuisen PW, Eikenboom JC, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2001; 21(5): 731-738. doi: 10.1161/01.ATV.21.5.731
- Wolberg AS, Sang Y. Fibrinogen and factor XIII in venous thrombosis and thrombus stability. Arteriosclerosis, Thrombosis, and Vascular Biology. 2022; 42(8): 931-941. doi: 10.1161/ATVBAHA.122.317164
- Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Current Opinion in Hematology. 2013; 20(5): 437-444. doi: 10.1097/MOH.0b013e3283634443
- Rhayem N, Ramah M. Overweight and obesity prevalence in North Africa: A systematic review and meta-analysis. Mediterranean Journal of Medicine and Medical Sciences. 2026; 2(3): 95-105. doi: 10.5281/zenodo.22123267
- Elmiladi SA GLP-1RA for glycemic control and obesity as add-on therapy for type 2 diabetes. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2023; 3(2): 45-50. doi: 10.5281/zenodo.7942952
- Nath D, Shivashekar M, Vinodhini VM. Fibrinogen levels in obese and normal individuals. Journal of Clinical and Diagnostic Research. 2019; 13(9): BC07-BC09. doi: 10.7860/JCDR/2019/42041.13162
- Larsson SC, Mason AM, Bäck M, Klarin D, Damrauer SM, Million Veteran Program, et al. Genetic predisposition to smoking in relation to 14 cardiovascular diseases. European Heart Journal. 2020; 41(35): 3304-3310. doi: 10.1093/eurheartj/ehaa193
- Zhang T. The related research of hypertension and deep venous thrombosis. China Journal of Modern Medicine. 2010. Corpus ID: 201928315.
- Bell EJ, Folsom AR, Lutsey PL, Selvin E, Zakai NA, Cushman M, et al. Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis. Diabetes Research and Clinical Practice. 2016; 111: 10-18. doi: 10.1016/j.diabres.2015.10.019
- Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003; 107(23 Suppl 1): I9-I16. doi: 10.1161/01.CIR.0000078469.07362.E6
- Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. The Lancet. 2016; 388(10063): 3060-3073. doi: 10.1016/S0140-6736(16)30514-1
- Muñoz Rodríguez FJ. Diagnosis of deep vein thrombosis. Revista Clinica Espanola. 2020: S0014-2565(20)30132-6. doi: 10.1016/j.rce.2020.03.009
- Neeman E, Liu V, Mishra P, Thai KK, Xu J, Clancy HA, et al. Trends and risk factors for venous thromboembolism among hospitalized medical patients. JAMA Network Open. 2022; 5(11): e2240373. doi: 10.1001/jamanet workopen.2022.40373
- Kujovich JL. Factor V Leiden thrombophilia. Genetics in Medicine. 2011; 13(1): 1-16. doi: 10.1097/GIM.0b013e 3181faa0f
Submitted date:
08/28/2026
Reviewed date:
10/28/2026
Accepted date:
11/03/2026
Publication date:
11/03/2026
